Issue 27, 2016

Synthesis and evaluation of neuroprotective 4-O-substituted chrysotoxine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease

Abstract

A series of 4-O-substituted chrysotoxine (CTX) derivatives were designed, synthesized and evaluated as multifunctional agents for the treatment of Alzheimer's disease (AD). In vitro assays indicated that four ring substituted compounds (2a, 2b, 3i and 3j) exhibited significant neuroprotective effects against Aβ25–35-induced toxicity in PC12 cells. The four compounds also inhibited self- and Cu2+-induced Aβ1–42 aggregation and acted as biometal chelators. In particular, compound 2a was a potential lead compound for AD treatment (cell viability up to 100.78% at 50 µM in Aβ25–35-treated PC12 cells, 51.88% and 58.03% inhibition at 25 µM for self- and Cu2+-induced Aβ1–42 aggregation, respectively). A metal chelating experiment showed that compound 2a had a moderate interaction with Cu2+ and Al3+. Moreover, western blot analysis showed that compound 2a attenuated Aβ-induced tau protein hyperphosphorylation at Ser199/202 and Ser396 sites. Furthermore, compound 2a could efficiently cross the blood-brain barrier (BBB) by a parallel artificial membrane permeability assay (PAMPA). In summary, these results suggested that compound 2a was a promising multifunctional compound for AD therapy.

Graphical abstract: Synthesis and evaluation of neuroprotective 4-O-substituted chrysotoxine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease

Supplementary files

Article information

Article type
Paper
Submitted
14 oct. 2015
Accepted
12 févr. 2016
First published
22 févr. 2016

RSC Adv., 2016,6, 22827-22838

Synthesis and evaluation of neuroprotective 4-O-substituted chrysotoxine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease

L. Guan, Y. Hao, L. Chen, M. Wei, Q. Jiang, W. Liu, Y. Zhang, J. Zhang, F. Feng and W. Qu, RSC Adv., 2016, 6, 22827 DOI: 10.1039/C5RA21313D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements